GE HealthCare reported fourth-quarter earnings per share of $1.44 from sales of $5.7 billion. Wall Street was looking for earnings per share of $1.40 from sales of $5.6 billion.

The market appears to have overreacted to some near-term margin pressure, but the reason for it is actually a long-term positive.

GE Aerospace posted robust Q4 and 2025 growth, with revenue up 20.4% and EPS up 38% year-over-year. Learn why GE stock is a Hold.

However, does this solid operational performance warrant further growth from current levels? We believe there is limited upside potential from the current

GE’s stock fell as earnings beat expectations, but the revenue outlook showed growth is decelerating.

According to data from Tikr.com, between 2024 and 2029, GE Aerospace is forecast to increase: Free cash flow from $3.67 billion to $10.50 billion. Adjusted EPS from $4.60 to $10.56. Annual dividend from $1.12 per share to $2.83 per share.

GE Aerospace stock drops despite beating Q4 estimates with $1.57 EPS and $11.9B revenue. Orders surge 74% but shares fall on high expectations.

GE HealthCare (Nasdaq: GEHC) shares got a boost today on fourth-quarter results that came in ahead of the consensus forecast.

Buying $100 In GE: If an investor had bought $100 of GE stock 5 years ago, it would be worth $546.06 today based on a price of $308.99 for GE at the time of writing.

In 2025, GE Vernova's Power business -- which sells heavy-duty gas turbines for combined-cycle plants, steam turbines for coal, gas, and nuclear plants, and provides fuel, maintenance, and upgrade services for nuclear plants -- accounted for 55% of its orders.

We recently published 11 Stocks on Jim Cramer’s Radar. GE Vernova Inc. (NYSE:GEV) is one of the stocks on Jim Cramer’s radar. GE Vernova Inc. (NYSE:GEV) is a nuclear power company that provides reactors.